According to estimates from 2019, more than one million of deaths and economic costs around the world are annually attributable to antibiotics-resistant infections. Thus, the antimi-crobial resistance is challenging for the public health, even if therisk assessment is not frequent and the real exposure risk is difficultto evaluate. [...]
Reychler, G., Verdereau, Z., Aubriot, A.-S., Gohy, S., Berardis, S., Boland, L., Haufroid, V., & Dubus, J.-C. (2025). Risk of Exposure for the Caregivers During Aminoglycoside Nebulization: An Observational Study. Archivos de Bronconeumologia, 61(6), 368-370. https://doi.org/10.1016/j.arbres.2025.01.011 (Original work published 2025)